Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:



Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue
Vol 17
No 4
Jul/Aug 2026
Keeping Up to Date in a New Era of Oncology
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, TCTCN, FAAN, FAPO
July 15, 2026
A Visual Fatigue Scale to Measure Cancer-Related Fatigue The Process of Development
Nina N. Grenon, DNP, AOCN, Elizabeth B. Russell, MS, PA-C, Mary Lou Siefert, DNSc, MBA, RN, AOCN, Et al.
July 15, 2026
Characteristics and Effectiveness of Targeted Melanoma Prevention Interventions for First Degree Relatives of Melanoma Survivors An Integrative Review
Jennie Clark, DNP, APRN, AGACNP-BC, AOCNP, CCRN, Ashley Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, NPD-BC, Joyce Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN Et al.
July 15, 2026